Informatics Methods for Leveraging Clinical Data Sources to Study Risk Factors for Alzheimer's Disease
Informatics Methods for Leveraging Clinical Data Sources to Study Risk Factors for Alzheimer's Disease
批准号:
10352791
负责人:
Rebecca Hubbard
金额:
$45.47万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-15 至 2025-01-31
关键词:
AccountingAddressAdultAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAutopsyBiological MarkersBrainCaringClinical DataClinical ResearchCodeCohort StudiesComplexDataData SetData SourcesDatabasesDevelopmentDiagnosisDiseaseDisease OutcomeDrug PrescriptionsEarly DiagnosisElectronic Health RecordEvaluationFamily memberGoalsHealth PersonnelHealth systemHealthcare SystemsHeterogeneityImageIndividualInformaticsInsurance CarriersKnowledgeLearningLinkMeasuresMedicalMethodologyMethodsNeurocognitiveOutcome MeasureParticipantPatient Care ManagementPatientsPatternPerformancePersonal SatisfactionPharmaceutical PreparationsPopulationPropertyPublic HealthResearchResourcesRiskRisk FactorsSTEM researchSamplingScanningSourceSystemTarget PopulationsTranslatingVariantWashingtonWorkbaseclinical databasecomorbiditycomplex datadata integrationdata qualitydeep learningelectronic dataflexibilityheterogenous datahigh dimensionalityimaging biomarkerimprovedindividual patientinsightinterestmiddle agemodifiable riskneuroimagingnovelprogramsresearch studystudy populationsymposiumtransfer learning
中文摘要
项目总结
英文摘要
Project Summary
Clinical data sources such as Electronic Health Records (EHR) and medical claims data have the potential to
serve as an enormous research resource to support goals such as identifying modifiable risk factors for
Alzheimer’s Disease (AD), but clinical data have significant limitations including data quality and missing data
challenges. To address these limitations, there is increasing interest in linking clinical data with research study
data. Connecting these data sources promises to synergize research-quality outcome measures based on
neuropathological data with rich information on potentially modifiable AD risk factors present in mid-life such as
co-morbid conditions and medication exposures that can be derived from clinical data. However, integrating
heterogeneous, inconsistently measured data types from a large clinical database (e.g., diagnosis codes,
prescription medications, imaging) with more consistently measured data on a smaller, targeted study
population requires development of novel informatics methodologies.
Recently proposed deep learning approaches have the potential to flexibly account for the complex data
availability patterns encountered in clinical data with improved predictive accuracy relative to traditional
methods. However, statistical properties of downstream analyses, such as bias and variance, have not yet
been evaluated following the application of these methods. Moreover, specialized methods are needed to
impute complex data types such as high-dimensional neuroimaging data. In addition to addressing
missingness within a clinical data-derived dataset, methods are needed to facilitate combining information from
clinical databases and research study data.
In this research, we propose to address the challenges of integrating clinical and research databases by
harnessing deep learning and transfer learning. We will use neuroimaging data from the Alzheimer’s Disease
Neuroimaging Initiative and cohort study data from the Adult Changes in Thought study in combination with
clinical data from the Kaiser Permanente Washington EHR to develop novel informatics approaches to
identification of risk factors for AD. In Aim 1, we will develop a deep learning approach to data integration for
heterogeneous clinical data linked to research study data, accounting for complex missing data patterns
encountered in clinical data. In Aim 2, we will develop a data integration framework to support transfer learning
from clinical data to research study data to advance statistical inference about risk factors for AD. The long-
term goal of our research program is to accelerate research on AD by facilitating integration of
heterogeneously collected clinical data and research study data to capitalize on the unique strengths of each
data source.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Improving confounder control in EHR-based studies of cancer epidemiology
-
批准号:9894108
-
项目类别:
-
资助金额:$1.88万
-
财政年份:2019
-
负责人:Rebecca Hubbard
-
依托单位:
Statistical Methods for Estimation of Benefits & Harms of Repeat Cancer Screening
-
批准号:8966955
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2015
-
负责人:Rebecca Hubbard
-
依托单位:
Statistical Methods for Estimation of Benefits & Harms of Repeat Cancer Screening
-
批准号:8636663
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2014
-
负责人:Rebecca Hubbard
-
依托单位:
Estimating the cumulative risk of a false-positive screening mammogram.
-
批准号:7893487
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2010
-
负责人:Rebecca Hubbard
-
依托单位:
Estimating the cumulative risk of a false-positive screening mammogram.
-
批准号:8034829
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2010
-
负责人:Rebecca Hubbard
-
依托单位:
海外基金